Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network...(combines decades of experience in intera...),Health
Navigation Links
Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
Date:9/25/2007
combines decades of experience in interactive media and medical, science and news journalism. The company received top recognition from The International Health and Medical Media Awards with a 2006 FREDDIE Award for MyDiabetesCentral.com and the Health Care Standard of Excellence WebAward from the Web Marketing Association.
'/>"/>
| SOURCE The HealthCentral Network, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Misleading anti-malarial drug
3. Misleading Advertisements for Prescription Drugs
4. The Effects Of Smoking Misleading
5. Antidepressant Medication Leading To Suicidal Thoughts
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Historic trial for tuberculosis launched together by leading drug companies
8. Alcohol And Drug Abuse (Cannabis) Leading Causes For Road Traffic Accidents
9. Down’s Syndrome Is The Leading Birth Defect In the U
10. Exposure to Grating, Noise, Music Can Cause Tumors Leading To Deafness
11. Bottleneck: High on Spirits Can Cause A Dispirited Liver, Leading To Cirrhosis!
Post Your Comments:
(Date:12/6/2009)... 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ... the pivotal Phase 2b 003-A1 study, known as ... in heavily pre-treated relapsed and refractory multiple myeloma ... ASH/ASCO Joint Symposium at the 51st annual meeting ... New Orleans. Enrollment in this trial is complete ...
(Date:12/6/2009)... site www.sleeping-with-a-sleeping-disorder.com is asking people ,who ... sleep aids from around the world to donate ... The submissions will be compiled in an ebook ... to be sold from the website in early ... the proceeds ,from sales of the E-book to ...
(Date:12/5/2009)... Dec. 5 There have been significant scientific advances ... continue to gain a better understanding of how certain ... and provide patients with the best care. Research presented ... Society of Hematology explores optimal induction therapies for managing ...
(Date:12/5/2009)... ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders ... presented today at the 51st Annual Meeting of ... treatment options and improved diagnostic methods for patients ... infant acute lymphoblastic leukemia, and myelofibrosis that are ...
(Date:12/5/2009)... today announced the launch of International Solutions, an innovative new international ... its UK equivalent. In addition to offering customers the flexibility to ... needs and budgets, International Solutions enables customers to tailor their benefits ... , ...
Breaking Medicine News(10 mins):Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2[0] Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability[0] Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You [0] New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer[0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders[0] AVIVA's Private Health Insurance Products Solutions Go International
... **SAVE THE DATE** April 14-16, 2009 in ... www.worldhealthcarecongress.com WOBURN, Mass., Feb. 19 At ... top leaders and innovators who are driving the $2.4 ... Safeway, Carlson Companies and Kelly Services who are responsible ...
... Founded Medical IT Company Launches into EXACENT,s Virtualized Environment , ... ... leading enterprise grade - on demand virtual data center , ... customer. , , ,HybridChart, a Scottsdale based company, has developed innovative ...
... blood pressure medicines helps maintain proper organ function, study ... combination of two blood pressure-lowering drugs reduced the risk ... with type 2 diabetes, according to researchers who analyzed ... patients. , The patients were randomly selected to receive ...
... difference, study finds, , , THURSDAY, Feb. 19 (HealthDay News) -- ... so-called Alzheimer,s gene might very well have the memory of ... This memory decline was not detected in people of middle ... the gene, known as ApoE4, according to the study. ...
... always been a vital issue for Americans but the current ... wellness. The two are far more closely related than people ... found that debt stress is a major contributor to health ... health problems, 20% more likely to have back pain and ...
... P&M Corporate Finance LLC, a,middle market investment banking ... Spine Technology Summit from RRY Publications. As part of ... will,continue to be actively involved in future Spine Technology ... 27, 2009 in London. , ...
Other Medicine News:Health News:6th Annual World Health Care Congress to Convene Preeminent Leaders for Three Days on Rebuilding Health Care 2Health News:6th Annual World Health Care Congress to Convene Preeminent Leaders for Three Days on Rebuilding Health Care 3Health News:EXACENT To Provide IT VIirtualization To HybridChart 2Health News:EXACENT To Provide IT VIirtualization To HybridChart 3Health News:Two-Drug Combo May Lower Diabetics' Kidney Risk 2Health News:If Parents Had Alzheimer's, Aging May Come Early 2Health News:If Parents Had Alzheimer's, Aging May Come Early 3Health News:Recession Spawns Vital New Industry - Financial Wellness 2Health News:Recession Spawns Vital New Industry - Financial Wellness 3Health News:P&M Corporate Finance Announces Acquisition of Spine Technology Summit, Partners with Robin Young to Present 2009 Conference in Canary Wharf London 26th Annual World Health Care Congress to Convene Preeminent Leaders for Three Days on Rebuilding Health CareEXACENT To Provide IT VIirtualization To HybridChartTwo-Drug Combo May Lower Diabetics' Kidney RiskIf Parents Had Alzheimer's, Aging May Come EarlyRecession Spawns Vital New Industry - Financial WellnessP&M Corporate Finance Announces Acquisition of Spine Technology Summit, Partners with Robin Young to Present 2009 Conference in Canary Wharf London
(Date:12/4/2009)... Technologies, Inc., developers of the AcceleDent System ... orthodontics, announced the availability of a new Continuing ... a leader in professional education for many industries, ... on patient views about orthodontic treatment, a summary ...
(Date:12/4/2009)... TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced ... Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected ... across the country. The grand prize is an in-person meeting ... type 1 diabetes like Nick, are: Caleb, age 6, from ...
(Date:12/4/2009)... ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced ... allowed its patent application on a system for automation ... Company,s DCVax® therapeutic cancer vaccines. These initial manufacturing ... dendritic cells (which are the critical ingredient) in the ...
Breaking Medicine Technology:AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5National Poll Finds Most Americans Believe Immigration Adversely Affects the Quality and Cost of Healthcare 57264 1National Poll Finds Most Americans Believe Immigration Adversely Affects the Quality and Cost of Healthcare 57264 2Cowen Announces Hiring of Don Munoz to Lead Medical Technology Practice 3B 5th Senior Level Addition to Cowens Health Care Franchise in 2009 57260 1Cowen Announces Hiring of Don Munoz to Lead Medical Technology Practice 3B 5th Senior Level Addition to Cowens Health Care Franchise in 2009 57260 2Indiana U medical researchers boost research and jobs with stimulus legislation grants 57257 1Indiana U medical researchers boost research and jobs with stimulus legislation grants 57257 2Indiana U medical researchers boost research and jobs with stimulus legislation grants 57257 3Indiana U medical researchers boost research and jobs with stimulus legislation grants 57257 4[0] AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell[0] Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced[0] Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing
... MACE, Zero Late Stent Thrombosis,- Company Also Provides Clinical Program Update ... ... -, WASHINGTON, Oct. 22 XTENT, Inc. (Nasdaq:,XTNT) today announced ... prospective studies evaluating the safety and,efficacy of its Custom NX(R) drug-eluting ...
... 21 Sanofi-aventis announced today,that the Japanese ... has granted,approval for a Supplemental New Drug ... syndrome (unstable angina pectoris, non-ST elevation,myocardial infarction) ... planned" for Plavix(R) (clopidogrel). Approximately 100,000 ...
Other Medicine Technology:XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System 2XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System 3XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System 4Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 2Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 3Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 4Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 5Suture retriever forceps...
Knife rasp for shoulder arthroscopy....
Knot pusher/suture retriever...
Loop handle knot pusher...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |